Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Analysts give Stevanato Group an average rating of "Hold" based on five covers (1 sell, 1 hold, 3 buys), with recent downgrades and price‑target cuts from Weiss, Wall Street Zen, Morgan Stanley and others.
• Several hedge funds modestly increased their stakes recently (e.g., Fifth Third Bancorp, First Bank & Trust, GW&K, Pathstone, Van Berkom), indicating some institutional buying interest across quarters.
• STVN opened at €17.56 with a 12‑month range of €12.89–€28.00 and a market cap of about $5.32 billion; latest quarter showed €0.18 EPS on €346.5M revenue, and analysts expect roughly 0.7 EPS for the year.

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have been assigned an average rating of "Hold" from the five ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company.

STVN has been the subject of a number of research reports. Weiss Ratings cut shares of Stevanato Group from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, March 11th. Jefferies Financial Group set a $17.50 price target on shares of Stevanato Group in a research report on Tuesday, February 10th. Morgan Stanley dropped their price target on shares of Stevanato Group from $24.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, March 6th. Citigroup dropped their price target on shares of Stevanato Group from $32.00 to $26.00 and set a "buy" rating for the company in a research report on Thursday, March 5th. Finally, Wall Street Zen lowered shares of Stevanato Group from a "buy" rating to a "hold" rating in a research report on Saturday, February 14th.

Hedge Funds Weigh In On Stevanato Group

A number of hedge funds have recently modified their holdings of STVN. Fifth Third Bancorp lifted its holdings in shares of Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company's stock worth $58,000 after buying an additional 773 shares in the last quarter. First Bank & Trust lifted its holdings in shares of Stevanato Group by 5.6% in the fourth quarter. First Bank & Trust now owns 17,109 shares of the company's stock worth $344,000 after buying an additional 904 shares in the last quarter. GW&K Investment Management LLC lifted its holdings in shares of Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company's stock worth $49,000 after buying an additional 1,055 shares in the last quarter. Pathstone Holdings LLC lifted its holdings in shares of Stevanato Group by 1.5% in the third quarter. Pathstone Holdings LLC now owns 71,178 shares of the company's stock worth $1,833,000 after buying an additional 1,067 shares in the last quarter. Finally, Van Berkom & Associates Inc. lifted its holdings in shares of Stevanato Group by 50.6% in the third quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company's stock worth $93,000 after buying an additional 1,215 shares in the last quarter.

Stevanato Group Stock Down 0.8%

Shares of STVN stock opened at €17.56 on Monday. Stevanato Group has a 12 month low of €12.89 and a 12 month high of €28.00. The stock has a market cap of $5.32 billion, a P/E ratio of 30.28, a P/E/G ratio of 1.59 and a beta of 0.75. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.23. The company has a 50 day simple moving average of €15.00 and a two-hundred day simple moving average of €18.87.

Stevanato Group (NYSE:STVN - Get Free Report) last announced its earnings results on Saturday, February 14th. The company reported €0.18 EPS for the quarter. Stevanato Group had a net margin of 11.83% and a return on equity of 10.44%. The business had revenue of €346.50 million during the quarter. On average, research analysts expect that Stevanato Group will post 0.7 earnings per share for the current year.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.